Recent News
National Asbestos Awareness Week: April 1 – April 7, 2017
On March 29, 2017 the U.S. Senate passed S. Res.98; a resolution designating the first week of April as “National Asbestos Awareness Week” in an attempt to warn and educate…
A Phase 2 Study of Durvalumab in Combination With Tremelimumab in Malignant Pleural Mesothelioma
Purpose: his research study is studying a pair of immunotherapies as a possible treatment for malignant pleural mesothelioma. The drugs involved in this study are Durvalumab and Tremelimumab.
Safety Study of MGD009 in B7-H3-expressing Tumors
Purpose: The purpose of this study is to evaluate the safety of MGD009 when given to patients with B7-H3-expressing tumors. The study will also evaluate what is the highest dose of MGD009 that can be given safely. Assessments will be done to see how the drug acts in the body (pharmacokinetics (PK), pharmacodynamics (PD) and to evaluate potential anti-tumor activity of MGD009.
Your Asbestosis Could Lead to Lung Cancer or Mesothelioma
Asbestosis, while not a cancerous condition, is serious and potentially life-threatening chronic disease that is caused by breathing in asbestos fibers. A person who has been diagnosed with asbestosis has…
Call Your State Senators to Oppose the Furthering Asbestos Claims Transparency Act
A new bill was approved by the U.S. House Judiciary Committee that could damage the asbestos claims process and prevent victims of asbestos-related diseases from ever seeing any sort of…
A Study of the Safety, Tolerability and Pharmacokinetics of ABBV-368 as a Single Agent and Combination in Subjects With Locally Advanced or Metastatic Solid Tumors
Purpose The primary purpose of this Phase 1, open-label study is to evaluate the safety, pharmacokinetics, and preliminary efficacy of ABBV-368 as a monotherapy and in combination with nivolumab in participants with locally advanced or metastatic solid tumors. The study will consist of 2 parts: ABBV-368 dose escalation and ABBV-368 tumor-specific dose expansion (non-small cell lung cancer [NSCLC] cohort and head and neck cancer cohort) .
Nutritional Status and Tumor Thickness Helps Determine Mesothelioma Prognosis
The overall nutritional health of a patient suffering from mesothelioma can have major impact on how the patient will respond to treatment, which affects patient survival. To determine a patient’s…
Atezolizumab and Bevacizumab in Rare Solid Tumors
Purpose: The goal of this clinical research study is to learn if atezolizumab and bevacizumab can help to control rare solid tumors.
Despite Asbestos Regulations, CDC Reports Increase in Mesothelioma
Mesothelioma is a type of cancer that is specifically caused by asbestos exposure. The cancer affects the lining surrounding various organs and cavities within the body called the mesothelium. Asbestos…
Partial Repeal in the ACA Preserves Provisions for Residents in Libby, Montana
The dangers of asbestos have affected thousands of residents in the small town of Libby, Montana for decades. In 1919, the town that was once known for its logging industry…
